When was Collaborative Drug Discovery founded?

Collaborative Drug Discovery was founded in 2004 and raised its 1st funding round 1 year after it was founded.

Where is Collaborative Drug Discovery located?

Collaborative Drug Discovery is headquartered in Burlingame, United States. It is registered at Burlingame, California.

How many employees does Collaborative Drug Discovery have?

As of Sep 30, 2026, the latest employee count at Collaborative Drug Discovery is 86.

Is Collaborative Drug Discovery a funded company?

Collaborative Drug Discovery is a funded company, having raised an undisclosed amount across 16 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2005.

When was the latest funding round of Collaborative Drug Discovery?

Collaborative Drug Discovery's latest funding was a $***** Grant (prize money) round on Apr 09, 2021, with participation from 1 investor. Its primary sector is Data as a Service. In United States, the Data as a Service sector has seen $908M in funding in 2026 to date.

Where does Collaborative Drug Discovery rank among its competitors?

Collaborative Drug Discovery ranks 16th amongst 178 active competitors, of which 22 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ArcaScience, which secured $7M in Jun, 2025.

Who are the top competitors of Collaborative Drug Discovery?

Collaborative Drug Discovery's top competitors include ESO, ArcaScience and Sanguine. Among them, ArcaScience secured the most recent funding round in June, 2025.

Collaborative Drug Discovery - 2026 Company Profile, Funding & Competitors

Company Details

Biological and chemical database to manage private and external data. Collaborative Drug Discovery offers CDD Vault - a biological and chemical database to manage private and external data securely. Users can organize chemical structures and biological study data, and collaborate with internal or external partners through web interface. It provides structure-aware tools for chemists and screening data tools for biologists. It allows users to selectively share data in real time with designated researchers claims to securely store experimental data in a private hosted vault and that it is protected with SSAE 16 Type II certified cloud storage on locked and guarded hardware.

Website: www.collaborativedrug.com/
Social
Registered Address: Burlingame, California

Key Metrics

Founded Year

2004

Location

Burlingame, United States

Stage

Series A

Latest Funding Round

Grant (prize money), Apr 09, 2021, $*****

Investors

Lilly & 5 more

Ranked

16^th among 178 active competitors

Employee Count

86 as on Sep 30, 2026

Similar Companies

ESO & 220 more

View Collaborative Drug Discovery's full profile

Collaborative Drug Discovery is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
COLLABORATIVE DRUG DISCOVERY, INC. CIN: 421631574 , United States, Active	Dec 26, 999	-	43 (As on Dec 31, 2024)	-

Collaborative Drug Discovery has raised funding over 16 rounds. Its first funding round was on 2005. Its latest funding round was a Grant (prize money) round on Apr 09, 2021 for $*****. 1 investor participated in its latest round. Collaborative Drug Discovery has 6 institutional investors.

Here is the list of recent funding rounds of Collaborative Drug Discovery:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2021	6702006	Grant (prize money)	1683281	6953836	3819285	4928264
Dec 19, 2019	9382811	Grant (prize money)	8062634	7175569	2000586	HHS
Aug 15, 2019	3249122	Grant (prize money)	8535388	8345512	3031422	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Collaborative Drug Discovery's funding rounds and investors

Collaborative Drug Discovery's employee count trend

Collaborative Drug Discovery has 86 employees as of Sep 26. Here is Collaborative Drug Discovery's employee count trend over the years:

Employee count trend for Collaborative Drug Discovery

Uncover Collaborative Drug Discovery's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Collaborative Drug Discovery include ESO, ArcaScience and Sanguine. Here is the list of Top 10 competitors of Collaborative Drug Discovery, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ESO 2004, Austin (United States), Series B	Provider of integrated software for emergency medical services	$50.4M	Austin Ventures, Golub Growth & 4 others	63/100
2nd	ArcaScience 2018, Paris (France), Seed	Developer of AI models for patient-centric insights in drug development	$7M	The Moon Venture, Kima Ventures & 5 others	53/100
3rd	Sanguine 2010, Los Angeles (United States), Series B	Building a databank of patient-derived data for advanced research	$5.53M	Broadoak Capital Partners, FCVC & 9 others	51/100
4th	MDI 2018, Seattle (United States), Series A	AI-based medication management tool for healthcare professionals	$27M	Hanaco Ventures, Intel Capital & 7 others	50/100
5th	Biorelate 2014, Manchester (United Kingdom), Series A	Developer of an artificial intelligence platform for biomedical literature curation and knowledge graph construction	$8.74M	YFM Equity Partners, Maven Capital Partners ... & 11 others	49/100
6th	Kudos 2013, Oxford (United Kingdom), Series A	Provider of research communication and showcase services. It helps researchers effectively communicate their work to a broader audience. The company offers tools and resources to enhance research visibility and impact. Services include creating engaging narratives around research findings and facilitating their dissemination across various platforms. This improves the reach and understanding of scientific discoveries.	$2.5M	Mobeus Equity Partners, Gleneagle Capital ... & 4 others	47/100
7th	ScienceIO 2020, Boston (United States), Acquired	Provider of AI solutions transforming medical text into enriched healthcare data	$8M	Sea Lane Ventures, Toba Capital & 13 others	43/100
8th	Animares 1997, Bonn (Germany), Unfunded	Developer of 3D medical animations and augmented, mixed, virtual reality	-	-	43/100
9th	KLAS 1996, Orem (United States), Unfunded	Healthcare data reports and insights provider	-	-	42/100
10th	Protocols.io 2012, Berkeley (United States), Seed	Life science protocol repository	$500K	Lighthouse Capital Management, Berkeley SkyDeck	41/100
16th	Collaborative Drug Discovery 2004, Burlingame (United States), Series A	Biological and chemical database to manage private and external data	-	Lilly, Gates & 4 others	37/100